Azoulay Salomon has filed 4 insider transactions across 1 company since September 2024.
Most recent transaction: a grant/award of 15000 shares of MBX Biosciences, Inc. ($MBX) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Common Stock | 15000 | $0.00 | 15,000.0000 | 44,902,302 | 9999.99% | 0.03% |
| Feb. 2, 2026 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock option (right to buy) | 70000 | $0.00 | 70,000.0000 | 44,902,302 | 9999.99% | 0.16% |
| Feb. 3, 2025 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 12, 2024 | MBX Biosciences, Inc. | $MBX | Azoulay Salomon | Chief Medical Officer | A | Stock Option (Right to Buy) | 45011 | $0.00 | 45,011.0000 | 0 | 9999.99% | 0.00% |